Abstract
To assess patient-reported pain relief in endometriosis (EM) for women receiving Elagolix (ELX), an oral gonadotrophin-releasing hormone (GnRH) antagonist, versus other treatments (Tx).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
